Pacira Pharmaceuticals Stock
Pacira Pharmaceuticals Stock
The Pacira Pharmaceuticals stock is trending slightly upwards today, with an increase of €0.20 (0.860%) compared to yesterday's price.
Currently there is a rather positive sentiment for Pacira Pharmaceuticals with 5 Buy predictions and 0 Sell predictions.
With a target price of 30 € there is a positive potential of 28.21% for Pacira Pharmaceuticals compared to the current price of 23.4 €.
Pros and Cons of Pacira Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pacira Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pacira Pharmaceuticals | 0.860% | 0.000% | 5.405% | 19.388% | 8.333% | -33.143% | -53.200% |
| Supernus Pharmaceuticals | 14.510% | 10.500% | 5.742% | 45.395% | 2.791% | 52.414% | 95.575% |
| Corcept Therapeutics Inc. | -1.800% | 15.059% | 21.989% | 53.499% | 39.222% | 235.211% | 423.077% |
| Collegium Pharmaceutical Inc | 0.000% | -2.548% | -4.969% | 15.038% | -26.087% | 54.545% | 48.544% |
Comments
Pacira BioSciences (PCRX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $38.00 price target on the stock.
Show more
Ratings data for PCRX provided by MarketBeat
Pacira BioSciences (PCRX) had its price target raised by Needham & Company LLC from $30.00 to $32.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PCRX provided by MarketBeat
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Show more
Ratings data for PCRX provided by MarketBeat